Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats

Nature Neuroscience

Volumn 1, Issue 4, 1998, Pages 290-295

  Studer, Lorenz ^a   Tabar, Viviane ^a,b   McKay, Ron D G ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; METABOLISM; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; RAT; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CULTURE TECHNIQUES; CYTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; TYROSINE 3-MONOOXYGENASE;

EID: 33644684826     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/1105     Document Type: Article

References (20)

1. Takayama, H. et al. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1, 53-58 (1995).
2. Choi-Lundberg, D. L. et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841 (1997).
3. Deacon, T. et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3, 350-353 (1997).
4. Olanow, C. W., Kordower, J. H. & Freeman, T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109 (1996).
5. Wenning, G. K. et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
6. Kordower, J. H. et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124 (1995).
7. Johe, K. K., Hazel, T. G., Müller, T., Dugich-Djordjevic, M. M. & McKay, R. D. G. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Devel. 10, 3129-3140 (1996).
8. McKay, R. D. Stem cells in the central nervous system. Science 276, 66-71 (1997).
9. Shah, N. M., Marchionni, M. A., Isaacs, I., Stroobant, P. & Andersen, D. J. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77, 349-360 (1994).
10. Shah, N. M., Groves, A. K. & Anderson, D. J. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell 85, 331-343 (1996).
11. Suhonen, J. O., Peterson, D. A., Ray, J. & Gage, F. H. Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature 383, 624-627 (1996).
12. Frederiksen, K. & McKay, R. D. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J. Neurosci. 8, 1144-1151 (1988).
13. Lendahl, U., Zimmerman, L. B. & McKay, R. D. CNS stem cells express a new class of intermediate filament protein. Cell 60, 585-595 (1990).
14. Guyenet, P. G. & Crane, J. K. Non-dopaminergic nigrostriatal pathway. Brain Res. 213, 291-305 (1981).
15. Rosenthal, A. Auto transplants for Parkinson's disease? Neuron 20, 169-172 (1998).
16. Spenger, C. et al. Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons. Exp. Brain Res. 112, 47-57 (1996).
17. Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247, 574-577 (1990).
18. Jiao, S., Gurevich, V. & Wolff, J. A. Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362, 450-453 (1993).
19. Fisher, L. J., Jinnah, H. A., Kale, L. C., Higgins, G. A. & Gage, F. H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron 6, 371-380 (1991).
20. Sabaté, O. et al. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat. Genet. 9, 256-260 (1995).